Markus Bruder
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Markus Bruder has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
Volker Seifert
Goethe University
15 shared publicationsGerhard Marquardt
Department of Neurosurgery, Goethe University, Frankfurt, Germany
6 shared publications- Juergen Konczalla
Department of Neurosurgery, Goethe-University Hospital, Schleusenweg 2 – 16, 60528 Frankfurt am Main, Germany
6 shared publications Matthias Setzer
Department of Neurosurgery, Goethe University, Frankfurt, Germany
4 shared publicationsNina Brawanski
Goethe University
4 shared publications- Christian Senft
Comprehensive Cancer Center Central Germany, Campus Jena, Jena University Hospital, Germany
3 shared publications
Latest Publications
- Open Access
- 25 May 2026
- Published by Wolters Kluwer Health in Spine Open
- Vol. 2 (2)
Axial Convergence in Percutaneous Robotic Pedicle Screw Placement: Mixed-Effects Analysis of 1006 Screws
Study Design: Retrospective single-center cohort study. Objective: To evaluate screw accuracy, axial trajectory characteristics relative to the anatomic pedicle axis (APA), and perioperative safety of robotic-assisted (RA) pedicle screw placement, and to determine whether percutaneous instrumentation (PI) enables reproducible medial trajectory modulation without increasing cortical breach rates. Summary of Background Data: RA pedicle screw placement achieves high categorical accuracy. However, most studies focus on breach rates and do not quantify systematic variation in axial screw angulation relative to the APA. Whether robotic workflows enable controlled trajectory modulation beyond simple intrapedicular containment remains unclear. Methods: A consecutive cohort of 146 adult patients undergoing RA pedicle screw placement using the CIRQ robotic arm (1006 screws) was analyzed. Accuracy was graded using the Gertzbein-Robbins classification (GR). Axial angulation and deviation from the APA were measured on postoperative computed tomography. Screw-level outcomes were assessed using multivariable mixed-effects regression accounting for case-level clustering. Sensitivity analyses addressed chronological case era and selection bias using inverse probability weighting. Results: Clinically acceptable placement (GR A/B) was achieved in 97.9% of screws; major malposition (GR D/E) occurred in 0.4%. Cervical location (OR: 7.10, P P P <0.001) without increased breach risk. Three screws (0.3%) required revision. No neurological deficits attributable to screw malposition were observed (mean follow-up 5.9 mo). Conclusions: RA pedicle screw placement using CIRQ achieved high accuracy and consistent safety independent of imaging modality and surgeon experience level. PI was associated with reproducible medial trajectory modulation without increased cortical breach. These findings suggest that RA permits controlled intrapedicular trajectory modulation within safe anatomic boundaries.
- 25 May 2026
- Published by Wolters Kluwer Health in Spine Open
- Vol. 2 (2)
Open AccessAxial Convergence in Percutaneous Robotic Pedicle Screw Placement: Mixed-Effects Analysis of 1006 Screws
Study Design: Retrospective single-center cohort study. Objective: To evaluate screw accuracy, axial trajectory characteristics relative to the anatomic pedicle axis (APA), and perioperative safety of robotic-assisted (RA) pedicle screw placement, and to determine whether percutaneous instrumentation (PI) enables reproducible medial trajectory modulation without increasing cortical breach rates. Summary of Background Data: RA pedicle screw placement achieves high categorical accuracy. However, most studies focus on breach rates and do not quantify systematic variation in axial screw angulation relative to the APA. Whether robotic workflows enable controlled trajectory modulation beyond simple intrapedicular containment remains unclear. Methods: A consecutive cohort of 146 adult patients undergoing RA pedicle screw placement using the CIRQ robotic arm (1006 screws) was analyzed. Accuracy was graded using the Gertzbein-Robbins classification (GR). Axial angulation and deviation from the APA were measured on postoperative computed tomography. Screw-level outcomes were assessed using multivariable mixed-effects regression accounting for case-level clustering. Sensitivity analyses addressed chronological case era and selection bias using inverse probability weighting. Results: Clinically acceptable placement (GR A/B) was achieved in 97.9% of screws; major malposition (GR D/E) occurred in 0.4%. Cervical location (OR: 7.10, P P P <0.001) without increased breach risk. Three screws (0.3%) required revision. No neurological deficits attributable to screw malposition were observed (mean follow-up 5.9 mo). Conclusions: RA pedicle screw placement using CIRQ achieved high accuracy and consistent safety independent of imaging modality and surgeon experience level. PI was associated with reproducible medial trajectory modulation without increased cortical breach. These findings suggest that RA permits controlled intrapedicular trajectory modulation within safe anatomic boundaries.
- Open Access
- 24 April 2026
- Published by Elsevier in Brain and Spine
- Vol. 6
Psoas muscle attenuation on preoperative CT predicts 30-day complications after lateral lumbar interbody fusion
- 24 April 2026
- Published by Elsevier in Brain and Spine
- Vol. 6
Open AccessPsoas muscle attenuation on preoperative CT predicts 30-day complications after lateral lumbar interbody fusion
- 1 January 2026
- Published by Georg Thieme Verlag KG
Degeneration
- 1 January 2026
- Published by Georg Thieme Verlag KG
Operationsverfahren im thorakolumbalen Bereich
- 3 November 2021
- Published by Georg Thieme Verlag KG in Die Wirbelsäule
- Vol. 05 (04) , 218-220
Kommentar zu: Wirbelsäulenchirurgie: Schützt Vancomycin-Puder vor Wundinfektionen?
Mit einer großen Zahl von fast 1000 eingeschlossenen Patienten haben sich Vakayil et al. dem Thema der topischen Applikation von Vancomycin (tAvV) in der Wirbelsäulenchirurgie genähert. Das „propensity score matching“ war sinnvoll, um eine gute Vergleichbarkeit der Gruppen zu erreichen. Allerdings wurde so die Zahl der in die Auswertung einbezogenen Patienten leider um mehr als die Hälfte reduziert. Um das Risikos für Wunddehiszenzen durch die lokale Anwendung von Vancomycin zu bewerten, war die Studienpopulation letztlich zu klein. Und auch für die sehr interessante Analyse der Vancomycin-Resistenzentwicklung war die Studie letztlich „underpowered“. Da die Patientencharakteristika auf die Resistenzentwicklung keinen Einfluss haben sollten, wäre eine Auswertung auch der ungematchten Patienten interessant gewesen. Am Ende zeigte die aufwendige statistische Auswertung keine Reduktion der Wundinfektionsraten durch die tAvV und die Studie reiht sich in das heterogene - „für und wider“ und „vielleicht“ - Bild der vorhandenen Literatur zu diesem Thema ein. Ist die tAvV in der Wirbelsäulenchirurgie wirklich ohne Wirkung, und die ganzen befürwortenden Studien nur das Ergebnis eines „publication bias“? Publication Date: 03 November 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 3 November 2021
- Published by Georg Thieme Verlag KG in Die Wirbelsäule
- Vol. 05 (04) , 218-220
Kommentar zu: Wirbelsäulenchirurgie: Schützt Vancomycin-Puder vor Wundinfektionen?
Mit einer großen Zahl von fast 1000 eingeschlossenen Patienten haben sich Vakayil et al. dem Thema der topischen Applikation von Vancomycin (tAvV) in der Wirbelsäulenchirurgie genähert. Das „propensity score matching“ war sinnvoll, um eine gute Vergleichbarkeit der Gruppen zu erreichen. Allerdings wurde so die Zahl der in die Auswertung einbezogenen Patienten leider um mehr als die Hälfte reduziert. Um das Risikos für Wunddehiszenzen durch die lokale Anwendung von Vancomycin zu bewerten, war die Studienpopulation letztlich zu klein. Und auch für die sehr interessante Analyse der Vancomycin-Resistenzentwicklung war die Studie letztlich „underpowered“. Da die Patientencharakteristika auf die Resistenzentwicklung keinen Einfluss haben sollten, wäre eine Auswertung auch der ungematchten Patienten interessant gewesen. Am Ende zeigte die aufwendige statistische Auswertung keine Reduktion der Wundinfektionsraten durch die tAvV und die Studie reiht sich in das heterogene - „für und wider“ und „vielleicht“ - Bild der vorhandenen Literatur zu diesem Thema ein. Ist die tAvV in der Wirbelsäulenchirurgie wirklich ohne Wirkung, und die ganzen befürwortenden Studien nur das Ergebnis eines „publication bias“? Publication Date: 03 November 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 28 October 2019
- Published by Springer Nature in Neurocritical Care
- Vol. 33 (1) , 105-114
Vitamin K Antagonist (Phenprocoumon) and Subarachnoid Hemorrhage: A Single-Center, Matched-Pair Analysis
Demographic changes are leading to an aging society with a growing number of patients relying on anticoagulation, and vitamin K antagonists (VKA) are still widely used. As mortality and functional outcomes are worse in case of VKA-associated hemorrhagic stroke, phenprocoumon treatment seems to be a negative prognostic factor in case of subarachnoid hemorrhage (SAH). The purpose of this study was to analyze whether phenprocoumon treatment does worsen the outcome after non-traumatic SAH.
- 28 October 2019
- Published by Springer Nature in Neurocritical Care
- Vol. 33 (1) , 105-114
Vitamin K Antagonist (Phenprocoumon) and Subarachnoid Hemorrhage: A Single-Center, Matched-Pair Analysis
Demographic changes are leading to an aging society with a growing number of patients relying on anticoagulation, and vitamin K antagonists (VKA) are still widely used. As mortality and functional outcomes are worse in case of VKA-associated hemorrhagic stroke, phenprocoumon treatment seems to be a negative prognostic factor in case of subarachnoid hemorrhage (SAH). The purpose of this study was to analyze whether phenprocoumon treatment does worsen the outcome after non-traumatic SAH.
- 22 June 2018
- Published by Springer Nature in Neurosurgical Review
- Vol. 42 (2) , 531-537
Pain medication at ictus of subarachnoid hemorrhage—the influence of one-time acetylsalicylic acid usage on bleeding pattern, treatment course, and outcome: a matched pair analysis
Acetylsalicylic acid (ASA) is a well-known and widely used analgesic for acute pain. Patients with acute headache due to subarachnoid hemorrhage (SAH) are inclined to take ASA in this situation. Due to the antithrombotic effects, ASA intake is related to higher bleeding rates in case of hemorrhage or surgical treatment. Between January 2006 and December 2016, 941 patients without continuous antithrombotic or anticoagulant medication were treated due to SAH in our institution. Fourteen of them (1.5%) had taken ASA as a single dose because of headache within 24 h before hospital admission. A matched pair analysis was performed. Admission status was good in 93% of patients with one-time use of ASA (OTA), but only in 59% of all other patients (p < 0.01). Bleeding pattern did not differ, but half of the patients with OTA had no identifiable bleeding source; this rate was significantly lower in the rest of the patients (p < 0.005). Aneurysm treatment and related complications did not differ between both groups. Cerebral vasospasm was more often only mild and rates of cerebral infarctions were lower in the OTA group but not on a significant level. Eighty-six percent of the OTA group and 84% (p = 0.8) of the matched pair control group reached favorable outcome according to mRS 6 months after SAH. Patients with OTA in case of SAH are usually in good clinical condition and bleeding pattern does not differ. In half of the patients with OTA, no bleeding source was detectable. In the case of aneurysm treatment, related complications did not differ and most of the patients reached favorable outcome. In the case of aneurysm treatment procedure, OTA does not influence treatment course and should not influence treatment decisions.
- 22 June 2018
- Published by Springer Nature in Neurosurgical Review
- Vol. 42 (2) , 531-537
Pain medication at ictus of subarachnoid hemorrhage—the influence of one-time acetylsalicylic acid usage on bleeding pattern, treatment course, and outcome: a matched pair analysis
Acetylsalicylic acid (ASA) is a well-known and widely used analgesic for acute pain. Patients with acute headache due to subarachnoid hemorrhage (SAH) are inclined to take ASA in this situation. Due to the antithrombotic effects, ASA intake is related to higher bleeding rates in case of hemorrhage or surgical treatment. Between January 2006 and December 2016, 941 patients without continuous antithrombotic or anticoagulant medication were treated due to SAH in our institution. Fourteen of them (1.5%) had taken ASA as a single dose because of headache within 24 h before hospital admission. A matched pair analysis was performed. Admission status was good in 93% of patients with one-time use of ASA (OTA), but only in 59% of all other patients (p < 0.01). Bleeding pattern did not differ, but half of the patients with OTA had no identifiable bleeding source; this rate was significantly lower in the rest of the patients (p < 0.005). Aneurysm treatment and related complications did not differ between both groups. Cerebral vasospasm was more often only mild and rates of cerebral infarctions were lower in the OTA group but not on a significant level. Eighty-six percent of the OTA group and 84% (p = 0.8) of the matched pair control group reached favorable outcome according to mRS 6 months after SAH. Patients with OTA in case of SAH are usually in good clinical condition and bleeding pattern does not differ. In half of the patients with OTA, no bleeding source was detectable. In the case of aneurysm treatment, related complications did not differ and most of the patients reached favorable outcome. In the case of aneurysm treatment procedure, OTA does not influence treatment course and should not influence treatment decisions.
- 1 May 2018
- Published by Elsevier in World Neurosurgery
- Vol. 113, e122-e128
Continuous Acetylsalicylic Acid Treatment Does Not Influence Bleeding Pattern or Outcome of Aneurysmal Subarachnoid Hemorrhage: A Matched-Pair Analysis
- 1 May 2018
- Published by Elsevier in World Neurosurgery
- Vol. 113, e122-e128
Continuous Acetylsalicylic Acid Treatment Does Not Influence Bleeding Pattern or Outcome of Aneurysmal Subarachnoid Hemorrhage: A Matched-Pair Analysis
- 1 February 2018
- Published by Elsevier in World Neurosurgery
- Vol. 110, e520-e525
Surgical Treatment of Spinal Synovial Cysts in Elderly Patients: Symptoms, Treatment Course, and Outcome in Patients >75 Years of Age
- 1 February 2018
- Published by Elsevier in World Neurosurgery
- Vol. 110, e520-e525
Surgical Treatment of Spinal Synovial Cysts in Elderly Patients: Symptoms, Treatment Course, and Outcome in Patients >75 Years of Age
- 1 October 2017
- Published by Elsevier in World Neurosurgery
- Vol. 106, 139-144
Subarachnoid Hemorrhage in Advanced Age: Comparison of Patients Aged 70–79 Years and 80 Years and Older
- 1 October 2017
- Published by Elsevier in World Neurosurgery
- Vol. 106, 139-144
Subarachnoid Hemorrhage in Advanced Age: Comparison of Patients Aged 70–79 Years and 80 Years and Older